Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
NA
Study on the therapeutic effect of different infusion times on tislelizumab...
Status
Recruiting
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Qingchun Campus) 3 Qingchun Road East, Shangcheng District, Hangzhou, Zhejiang, China
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery
PHASE1
This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer
PHASE3
The goal of this clinical trial is to learn if diphenhydramine can improve ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery
PHASE1
This is a Phase I, single-arm, open-label, dose-escalation study in patient...
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study
PHASE2
This is a phase II open-label study to evaluate the efficacy and safety of ...